… of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study

C Lu, XR Dong, J Zhao, XC Zhang, HJ Chen… - Journal of Hematology & …, 2020 - Springer
… the immuno-characteristics in those patients have also not been well characterized in previous
studies [16, 17]. Here, we describe genetic and immune profiling in a multicenter cohort of …

Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study

A De Hollanda, A Beucher, D Henrion… - … care & research, 2011 - Wiley Online Library
… of this study was to determine the clinical features and … Here we report a multicenter
retrospective study (2002–2009) … Exclusion criteria consisted of immunosuppressive therapy …

Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy

PU Ogbogu, BS Bochner, JH Butterfield… - … and Clinical Immunology, 2009 - Elsevier
… With the exception of a recent multicenter trial of mepolizumab (anti–IL-5 mAb),
published therapeutic experience has been restricted to case reports and small case series. …

Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study

B Martire, R Rondelli, A Soresina, C Pignata… - … immunology, 2008 - Elsevier
… Up to now, despite several decades of work on CGD, only a few large multicenter studies
have been … a multicenter retrospective survey of 60 patients with a definitive diagnosis of CGD. …

New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases

K Yamada, M Yamamoto, T Saeki, I Mizushima… - Arthritis research & …, 2017 - Springer
… The aim was to further characterize immunoglobulin G4-related disease (IgG4-RD) by a
large-scale multicenter study of its clinical and laboratory features conducted by multidisciplinary …

Granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID): a multicenter retrospective study of patients from Italian …

F Cinetto, R Scarpa, M Carrabba, D Firinu… - … in Immunology, 2021 - frontiersin.org
… we enrolled 73 CVID patients with radiologic features of interstitial lung disease (ILD) … Italian
multicenter study on CVID patients affected by interstitial lung disease (ILD). In our study we …

… characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

F Passamonti, C Cattaneo, L Arcaini, R Bruna… - The Lancet …, 2020 - thelancet.com
… Data on patient characteristics and outcomes were extracted by study investigators from
electronic medical records or clinical charts, including age, sex, Charlson Comorbidity Index, …

A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma

ON Kozyreva, D Chi, JW Clark, H Wang… - The …, 2011 - academic.oup.com
… In this retrospective multicenter study, we compared the clinical characteristics, treatment
modalities, and outcome data for elderly (age ≥70 years) compared to younger patients (age <…

Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study

A Plebani, A Soresina, R Rondelli, GM Amato… - … immunology, 2002 - Elsevier
… epigenetic factors may influence the immunological phenotype, as the … On the other hand,
an immunological phenotype compatible … As a whole, our data confirm that the immunological

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study

Z Shao, Y Feng, L Zhong, Q Xie, M Lei… - … immunology, 2020 - Wiley Online Library
… To our knowledge, this multicenter retrospective cohort study is the first clinical evaluation,
with a large number of cases, on the efficiency of IVIG treatment to critical COVID-19 patients. …